UP Philippine General Hospital Division of Endocrinology, Diabetes & Metabolism Consensus recommendations for in-Patient managementof Diabetes Mellitus among persons with COVID-19
- Author:
Cecilia Jimeno
1
;
Ma. Cecille Anonuevo-Cruz
1
;
Angelique Bea Uy
1
;
Adrian Oscar Bacena
1
;
Mark David Francisco
1
;
Angelique Love Tiglao-Gica
1
;
Racquel Bruno
1
;
Diane Grace Corpuz
1
Author Information
- Publication Type:Journal Article
- Keywords: In-patient management; Diabetes
- MeSH: COVID-19; SARS-COV-2
- From: Journal of the ASEAN Federation of Endocrine Societies 2020;35(1):14-25
- CountryPhilippines
- Language:English
- Abstract: Diabetes mellitus (DM) is a known risk factor for morbidity and mortality among patients with COVID-19 based on recent studies. While there are many local and international guidelines on inpatient management of diabetes, the complicated pathology of the virus, the use of glucose-elevating drugs such as glucocorticoids, antivirals and even inotropes, and various other unique problems has made the management of in-hospital hyperglycemia among patients with COVID-19 much more difficult than in other infections. The objective of this guidance is to collate and integrate the best available evidence that has been published regarding in-patient management of diabetes among patients with COVID-19. A comprehensive review of literature was done and recommendations have been made through a consensus of expert endocrinologists from the University of the Philippines-Philippine General Hospital (UP-PGH) Division of Endocrinology, Diabetes and Metabolism. These recommendations are evolving as we continue to understand the pathology of the disease and how persons with diabetes are affected by this virus.
- Full text:821-Article Text-9831-5-10-20200530.pdf
